Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
UBS
US Department of Justice
Fuji
Queensland Health
Medtronic
AstraZeneca
Novartis
Cerilliant
Dow

Generated: January 17, 2018

DrugPatentWatch Database Preview

Hec Pharm Usa Inc Company Profile

« Back to Dashboard

What is the competitive landscape for HEC PHARM USA INC, and what generic and branded alternatives to HEC PHARM USA INC drugs are available?

HEC PHARM USA INC has two approved drugs.



Summary for Hec Pharm Usa Inc
US Patents:0
Tradenames:2
Ingredients:2
NDAs:2
Drug Master File Entries: 2

Drugs and US Patents for Hec Pharm Usa Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hec Pharm Usa Inc CLARITHROMYCIN clarithromycin TABLET;ORAL 203584-001 Sep 28, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hec Pharm Usa Inc CLARITHROMYCIN clarithromycin TABLET;ORAL 203584-002 Sep 28, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hec Pharm Usa Inc ZIDOVUDINE zidovudine TABLET;ORAL 202058-001 Oct 7, 2011 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
QuintilesIMS
Farmers Insurance
McKinsey
US Department of Justice
Cerilliant
Chubb
Accenture
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot